Akoustis Technologies Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Akoustis Technologies stock.
View analyst ratings for Akoustis Technologies or view top-rated stocks.

Wall Street analysts have given Akoustis Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Akoustis Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Akoustis Technologies saw a decrease in short interest during the month of February. As of February 26th, there was short interest totaling 3,790,000 shares, a decrease of 19.5% from the February 11th total of 4,710,000 shares. Based on an average daily volume of 996,600 shares, the short-interest ratio is currently 3.8 days.
View Akoustis Technologies' Short Interest.

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Monday, May 3rd 2021.
View our earnings forecast for Akoustis Technologies.

Akoustis Technologies, Inc. (NASDAQ:AKTS) posted its earnings results on Sunday, January, 31st. The technology company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.06. The technology company had revenue of $1.31 million for the quarter, compared to analyst estimates of $1.04 million. Akoustis Technologies had a negative net margin of 2,077.27% and a negative trailing twelve-month return on equity of 72.62%.
View Akoustis Technologies' earnings history.

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AKTS stock has increased by 123.2% and is now trading at $11.85.
View which stocks have been most impacted by COVID-19.

5 Wall Street analysts have issued 1-year price targets for Akoustis Technologies' shares. Their forecasts range from $17.00 to $25.00. On average, they expect Akoustis Technologies' stock price to reach $20.20 in the next year. This suggests a possible upside of 70.5% from the stock's current price.
View analysts' price targets for Akoustis Technologies or view top-rated stocks among Wall Street analysts.

Some companies that are related to Akoustis Technologies include Plantronics (PLT), Telkom SA SOC (TLKGY), NETGEAR (NTGR), AudioCodes (AUDC), ADTRAN (ADTN), Clearfield (CLFD), DZS (DZSI), Sunworks (SUNW), Franklin Wireless (FKWL), Zoom Telephonics (MINM), Zoom Telephonics (ZMTP), Altigen Communications (ATGN), Communications Systems (JCS), ClearOne (CLRO) and Sonim Technologies (SONM).
View all of AKTS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Editas Medicine (EDIT), Marvell Technology Group (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Akoustis Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Clarus Group Inc. (0.94%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends for Akoustis Technologies.

AKTS stock was acquired by a variety of institutional investors in the last quarter, including Clarus Group Inc..
View insider buying and selling activity for Akoustis Technologies or or view top insider-buying stocks.

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AKTS stock can currently be purchased for approximately $11.85.

Akoustis Technologies has a market capitalization of $502.36 million and generates $1.79 million in revenue each year. The technology company earns $-36,140,000.00 in net income (profit) each year or ($0.86) on an earnings per share basis.

Akoustis Technologies employs 95 workers across the globe.

The official website for Akoustis Technologies is www.akoustis.com.

Akoustis Technologies is headquartered at 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078.

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]